Try GARD® – Genomic Allergen Rapid Detection. The most accurate and informative in vitro skin and respiratory sensitization test for:

  • Screening of pharmaceutical candidates
  • Safety assessment of chemicals
  • Safety assessment of cosmetic ingredients
  • Potency classification of skin sensitizers Categorizing 1A / 1B
  • Safety assessment of complex mixtures and pre- and pro haptens

SenzaGen is specializing in genomics-based methodology for immunotoxicological assays. Our proprietary lead product, GARD®, utilizes genomic biomarker signatures of hundreds of genes relevant for hazard prediction.

Doing so, it predicts and classifies chemical sensitizers with a state-of-the-art predictive performance.